Details for New Drug Application (NDA): 021408
✉ Email this page to a colleague
The generic ingredient in MENTAX-TC is butenafine hydrochloride. There are two drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
Summary for 021408
| Tradename: | MENTAX-TC |
| Applicant: | Pharmobedient |
| Ingredient: | butenafine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 1% | ||||
| Approval Date: | Oct 17, 2002 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
